Enzalutamide Sandoz

Enzalutamide Sandoz is an oral medication used to treat certain types of cancer. This prescription drug is manufactured by Sandoz Polska Sp. Z O.O. and is available in the EU market.

Enzalutamide Sandoz is primarily used in the treatment of prostate cancer. It works by blocking the effects of androgens, which are hormones that can promote the growth of cancer cells. This medication is often prescribed for patients who have not responded to other treatments. Enzalutamide is used for managing advanced prostate cancer, focusing on reducing tumor growth and spread.

Common effects of Enzalutamide Sandoz may include fatigue, hot flashes, and joint pain. Some users might experience dizziness or headaches. It's important to note that individual responses to the medication can vary, and not everyone will experience these effects. Always consult a healthcare provider for personalized advice.

Enzalutamide Sandoz should be handled with care, following the prescribed dosage and administration guidelines. It is essential to inform your healthcare provider about any existing medical conditions or allergies before starting this medication. Pregnant women or those planning to become pregnant should avoid handling this medication due to potential risks.

Enzalutamide Sandoz may interact with certain medications, including those metabolized by the liver's CYP3A4 enzyme. It is advisable to avoid alcohol while taking this medication, as it can increase the risk of side effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.